No paralogue variants have been mapped to residue 181 for KCNQ1.
KCNQ1 | TGT-LF-WMEIVLVVFFGTEYVVRLWSAGC>R<SKYVGLWGRLRFARKPISIIDLIVVVASMV | 211 |
KCNQ2 | EGA-LY-ILEIVTIVVFGVEYFVRIWAAGC>C<CRYRGWRGRLKFARKPFCVIDIMVLIASIA | 181 |
KCNQ3 | GDW-LL-LLETFAIFIFGAEFALRIWAAGC>C<CRYKGWRGRLKFARKPLCMLDIFVLIASVP | 211 |
KCNQ4 | NEC-LL-ILEFVMIVVFGLEYIVRVWSAGC>C<CRYRGWQGRFRFARKPFCVIDFIVFVASVA | 187 |
KCNQ5 | SSC-LL-ILEFVMIVVFGLEFIIRIWSAGC>C<CRYRGWQGRLRFARKPFCVIDTIVLIASIA | 215 |
KCNA1 | TDP-FF-IVETLCIIWFSFELVVR------>-<--FFACPSKTDFFKNIMNFIDIVAIIPYFI | 267 |
KCNA10 | TDP-FF-MVESTCIVWFTFELVLR------>-<--FVVCPSKTDFFRNIMNIIDIISIIPYFA | 317 |
KCNA2 | TDP-FF-IVETLCIIWFSFEFLVR------>-<--FFACPSKAGFFTNIMNIIDIVAIIPYFI | 268 |
KCNA3 | SDP-FF-VVETLCIIWFSFELLVR------>-<--FFACPSKATFSRNIMNLIDIVAIIPYFI | 341 |
KCNA4 | NDP-FF-IVETVCIVWFSFEFVVR------>-<--CFACPSQALFFKNIMNIIDIVSILPYFI | 417 |
KCNA5 | ADP-FF-IVETTCVIWFTFELLVR------>-<--FFACPSKAGFSRNIMNIIDVVAIFPYFI | 370 |
KCNA6 | TDP-FF-LVETLCIVWFTFELLVR------>-<--FSACPSKPAFFRNIMNIIDLVAIFPYFI | 309 |
KCNA7 | NDP-FF-VVETLCICWFSFELLVR------>-<--LLVCPSKAIFFKNVMNLIDFVAILPYFV | 255 |
KCNB1 | DNPQLA-HVEAVCIAWFTMEYLLR------>-<--FLSSPKKWKFFKGPLNAIDLLAILPYYV | 275 |
KCNB2 | DNRQLA-HVEAVCIAWFTMEYLLR------>-<--FLSSPNKWKFFKGPLNVIDLLAILPYYV | 279 |
KCNC1 | TEA-FLTYIEGVCVVWFTFEFLMR------>-<--VIFCPNKVEFIKNSLNIIDFVAILPFYL | 291 |
KCNC2 | TDP-ALTYVEGVCVVWFTFEFLVR------>-<--IVFSPNKLEFIKNLLNIIDFVAILPFYL | 328 |
KCNC3 | TEP-FLTYVEGVCVVWFTFEFLMR------>-<--ITFCPDKVEFLKSSLNIIDCVAILPFYL | 394 |
KCNC4 | TEP-ILTYIEGVCVLWFTLEFLVR------>-<--IVCCPDTLDFVKNLLNIIDFVAILPFYL | 327 |
KCND1 | PQA-FF-CMDTACVLIFTGEYLLR------>-<--LFAAPSRCRFLRSVMSLIDVVAILPYYI | 277 |
KCND2 | AVA-FF-CLDTACVMIFTVEYLLR------>-<--LAAAPSRYRFVRSVMSIIDVVAILPYYI | 275 |
KCND3 | SVA-FF-CLDTACVMIFTVEYLLR------>-<--LFAAPSRYRFIRSVMSIIDVVAIMPYYI | 272 |
KCNF1 | EHPTLE-NVETACIGWFTLEYLLR------>-<--LFSSPNKLHFALSFMNIVDVLAILPFYV | 268 |
KCNG1 | CHN-VF-IVESVCVGWFSLEFLLR------>-<--LIQAPSKFAFLRSPLTLIDLVAILPYYI | 314 |
KCNG2 | CRS-LF-VLETVCVAWFSFEFLLR------>-<--SLQAESKCAFLRAPLNIIDILALLPFYV | 264 |
KCNG3 | REP-SG-IIEAICIGWFTAECIVR------>-<--FIVSKNKCEFVKRPLNIIDLLAITPYYI | 267 |
KCNG4 | CYY-IF-IVETICVAWFSLEFCLR------>-<--FVQAQDKCQFFQGPLNIIDILAISPYYV | 308 |
KCNS1 | DDPVLR-RLEYFCIAWFSFEVSSR------>-<--LLLAPSTRNFFCHPLNLIDIVSVLPFYL | 318 |
KCNS2 | EDPRFE-IVEHFGIAWFTFELVAR------>-<--FAVAPDFLKFFKNALNLIDLMSIVPFYI | 273 |
KCNS3 | DDPVLE-GVEIACIAWFTGELAVR------>-<--LAAAPCQKKFWKNPLNIIDFVSIIPFYA | 268 |
KCNV1 | DLQLLE-ILEYVCISWFTGEFVLR------>-<--FLCVRDRCRFLRKVPNIIDLLAILPFYI | 288 |
KCNV2 | LRPILE-HVEMLCMGFFTLEYLLR------>-<--LASTPDLRRFARSALNLVDLVAILPLYL | 348 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.R181C | c.541C>T | Putative Benign | rs199473395 | SIFT: tolerated Polyphen: probably damaging | |
Reports | Putative Benign | Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. Circulation. 2009 120(18):1752-60. 19841300 | |||
Unknown | Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy. Heart. 2015 101(4):294-301. doi: 10.1136/heartjnl-2014-306387. 25351510 |